1 |
Decreased the expression of CLDN-1, CLDN-3, ZO-1 and ZO-2 |
B. licheniformis H2 |
Increased the expression of these proteins |
[12] |
2 |
Reduced the expression of IGF-1 and EGF in the gut |
Multi probiotic strain. B. subtilis
|
Increased IGF-1 and EGF in the jejunum and ileum |
[18] |
3 |
Increased expression of CLDN3, |
Multi strain |
Decreased CLDN3; increased CLDN3 and Muc-2 on day 42 |
[19] |
4 |
Reduced the expression of CLDN-3 |
B. licheniformis
|
Increased the expression of CLDN-3 |
[23] |
5 |
Reduced mRNA expression of Muc2; reduced IAP activity |
B. coagulans
|
No effect on mucin expression; increased IAP activity in the jejunum |
[25] |
6 |
Decreased CLDN-1 but had no influence on OCLDN and CLDN-2 |
L. fermentum, B. coagulans
|
Increased CLDN-3 |
[26] |
7 |
Reduced mRNA expression of CLDN-3, CLDN-1 and ZO-2 |
Primlac: multi strain probiotics |
Increased expression of these proteins |
[94] |
8 |
Reduced expression of CLDN-1 and OCLDN transcripts; increased Muc-2 |
B. subtilis DSM29784 |
No effect on expression of claudins |
[95] |
9 |
Increased level of serum DAO and reduced CLDN-3 and MUC-2 |
B. amyloliquefaciens BLCC1-0238 |
Reduced level of serum DAO and D-lactic acid; increased OCLN, ZO-1 and MUC2 |
[110] |
10 |
Reduced CLDN-3 and ZO-1; increased MLCK mRNA expression |
E. faecium
|
Increased expression of CLDN-1 |
[112] |
11 |
Reduced JAM2 |
B. licheniformis
|
Increased JAM2 |
[122] |